Monthly Economic Monitoring of Ukraine No 231, April 2024
Whats next for WHO (world health organization)
1. WHO – World Health
Organization
PAUL YOUNG CPA CGA
APRIL 9, 2020
2. Paul Young - Bio
• CPA, CGA
• Academia (PF1, FA4 and MS2)
• SME – Risk Management
• SME – Close, Consolidate and Reporting
• SME – Public Policy
• SME – Emerging Technology
• SME – Financial Solutions
• SME – Business Process Change
• SME – Supply Chain Management
Contact information:
Paul_Young_CGA@Hotmail.com
3. Agenda
WHO – Mandate
WHO – Membership / Board
Member countries
WHO Funding
Oversight
Stats / COVID19
Other Training/Development
How to transform the WHO
5. Board Members
Source - https://apps.who.int/gb/gov/en/composition-of-the-board_en.html
Best Healthcare System Ranking
6. Member Countries
Source - https://www.who.int/countries/en/
No Taiwan
WHO praises China, but refuses to discuss
Taiwan
https://www.who.int/bulletin/volumes/85/07-
100107/en/index1.html
8. Oversight and Performance Audits
Source – WHO
• Internal audits in the past have show
issues with effectiveness of programs
and/or oversight
• All donors should be asking for more
performance audits as part of
assessing the effectiveness of WHO
programs
• An annual audited risk management
report should be provided including
assessing global risk, crisis
management, etc.
• More work needs to be done in terms
of using data sciences and analytics as
part of managing various programs
with WHO
10. USA Funding
Source - https://www.ft.com/content/193453e3-479f-4fef-9234-d0f9f14c5a6e
11. Training and Development
If you like to learn more
about trade and/or other
subjects as part of your
professional learning and
development then feel free
to review my material on
https://www.udemy.com/
(search Paul Young CPA
CGA)
These subjects address
how to fixed issues with
housing and/or systemic
issues related to economy
including government
policies
12. What’s should be next for WHO
More oversight into programs including performance audits
More accountability and transparency when it comes to management of
programs including crisis management.
More oversight into risk management including risk management reporting
(mitigation of risks)
Adjusting the board to include both donors and country representation
i.e. pharma, technology, health experts, etc.